Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
The company reported financial results for the second quarter ended June 30, 2019.
Read More
Select Page
Aug 6, 2019 | 1
The company reported financial results for the second quarter ended June 30, 2019.
Read MoreAug 1, 2019 | 1
The quarterly payment will increase to $0.58 per share.
Read MoreAug 1, 2019 | 0
Q1 Revenues Gain 58% Compared to Prior Year.
Read MoreJul 31, 2019 | 1
U.S. Consumer segment sales increase 10% in Q3, up 9% year-to-date.
Read MoreJul 29, 2019 | 0
The redemption price for the notes, payable in cash, will include a make-whole premium of...
Read MoreJul 29, 2019 | 0
The company has reached an agreement in principle (the “Extension Agreement”) to extend the due date for the US$9,527,350 earn-out payment due to Chalice LLC (“Chalice”) and its members.
Read MoreJul 26, 2019 | 0
Farmers can now grow and sell hemp-based products at close to $40 a pound compared to their previous crops which sold at close to $1 a pound, in the case of kale.
Read MoreJul 17, 2019 | 0
The company has signed CBD extraction contracts with hemp cultivation operations worth $15 million in total.
Read MoreJul 5, 2019 | 0
NOUV is expanding its conventional Texas based nursery operation into a major hemp farming operation.
Read MoreJun 28, 2019 | 0
Constellation is the No. 3 beer company in the U.S. with high-end, iconic imported beer brands such as the Corona and Modelo brand families, and Pacifico.
Read MoreGet stock alerts, news & related alerts straight to your inbox!